Login

My Account

AHNTI EU announces 2026 Innovation Showcase finalists

Innovation is reshaping the future of animal health, accelerating earlier diagnosis, improving welfare outcomes, advancing sustainability in food systems, and enabling new therapeutic and preventive solutions at scale.

As global challenges continue to grow across companion animal care and livestock production alike, the need for breakthrough thinking and investable innovation has never been greater.

As in 2024, attendees will hear from the curated group of early-stage companies identified as the “ones to watch” across nutrition, diagnostics, biopharma, and technology. Photograph: AHNTI EU

That is why AHNTI EU (Animal Health, Nutrition & Technology Innovation) has announced its 2026 Innovation Showcase finalists, a curated group of early-stage companies identified as the “ones to watch” across Nutrition, Diagnostics, Biopharma, and Technology.

The finalists will take to the stage 2 March in London at Convene St Paul’s, pitching live during AHNTI EU in front of an audience of 850+ industry leaders, investors, pharma, biotech, CDMOs, and strategic partners.

Selected by AHNTI’s prestigious selection committee of investors and industry leaders, the finalists represent some of the most exciting emerging solutions in the market, each demonstrating strong potential to transform the animal health ecosystem and create meaningful opportunities for partnership and investment.

The event, which takes place from 2-4 March, will also offer opportunities for strategic discussions and follow-on meetings throughout the three days.

The 2026 AHNTI EU Innovation Showcase finalists

BIOPHARMA

BioAZ – Biotechnology company advancing animal health and welfare through high-impact scientific solutions.
Modulant Bioscience – Small molecule therapeutics targeting multiprotein complexes involved in infectious and chronic disease.
NanoVet Biotech – Camelid-derived nanobodies and biologics with programmes spanning dermatology, cancer therapies, osteoarthritis, and kidney disease.
Pasture Biosciences – Developing next-generation veterinary vaccines, including a cattle vaccine aiming to improve feed efficiency and reduce methane emissions.

NUTRITION

Agteria Biotech – Developing a methane-reducing compound for cattle to help cut agricultural emissions while maintaining health and productivity.
NanosVet – Needle-free medicine through dissolvable oral nanostrips, launching with an epi-pen equivalent for pets.
Pet Diet Plans – Personalised diet plans and practical nutrition support for long-term pet wellness and quality of life.
PhageLab – Bacteriophage-based solutions supporting alternatives to antibiotics and addressing antimicrobial resistance.

TECHNOLOGY

Athian – Carbon marketplace for livestock to aggregate, verify, and monetise on-farm greenhouse gas reductions.
MariHealth Solutions – Bioinformatics and deep data analytics turning biological data into actionable insights for animal health and nutrition.
Photon Therapeutics – Ophthalmic research and clinical science collaboration developing compliant, patient-focused solutions.
Vet Vision AI – AI-driven machine vision and real-time monitoring for welfare, behaviour, and health insights to support earlier intervention.

DIAGNOSTICS

PrediPet – Simple blood test to detect, monitor, and screen for cancer and tumour-related disease in dogs.
InsituGen – Patented bioassay technology measuring steroid hormone bioactivity for sensitive, non-targeted screening.
Pictor – Multiplex proteomics and ELISA-based testing for human and animal health with faster turnaround and lower cost.
PRONOVA – At-home saliva-based biosensor platform for dogs delivering biomarker insights in ~15 minutes via mobile app.

To learn more about the finalists, visit: ahnti-eu.com/events/ahnti-eu/innovation

To register for AHNTI EU 2026, visit: ahnti-eu.com/events/ahnti-eu/register

Why not try these links to see what our Fish Farmer AI can tell you.
(Please note this is an experimental service)

How do methane-reducing compounds improve cattle health and reduce emissions?What advantages do camelid-derived nanobodies offer in veterinary treatments?How can AI-driven machine vision enhance early animal health interventions?What innovations enable needle-free medicine delivery for pets?How does the carbon marketplace verify and monetize livestock emissions reductions?

Marine Operative - Bakkafrost Scotland Limited

PA21 2DA£35,677.16 per annum

Deckhand (Argyll Net Washer) - Mowi Scotland

Argyll & Bute£28,258 to £31,648 per annum

Freshwater Advanced Husbandry Operator - Landcatch Ltd

OrmsarySalary On Application

HGV Driver - Mowi Scotland

RosythSalary On Application

Hygiene Operative - Night - Bakkafrost Scotland Limited

Cairndow£33,273.52 per annum

100 jobs may go as Bremnes calls time on Salma brand

Sea Farming15 Jan 2025

15,000 fish escape at Lerøy site

Land Based Farming & Hatcheries18 Dec 2025

20,000 farmed fish die after power failure

Sea Farming30 Oct 2024

2023 saw Scottish salmon production fall 11%

Sign up to our daily Newsletters

We at Fish Farmer Magazine endeavour to ensure that all our reports are fair and accurate and comply with the Editors’ Code of Practice set by the Independent Press Standards Organisation (IPSO). We realise, however, that mistakes happen from time to time. If you think we have made a significant mistake and you wish to discuss this with us, please let us know as soon as possible by any of the three methods: emailing editor@fishfarmermagazine.com; telephoning the editor on 01315517949 ; writing to the Editor at Fish Farmer Magazine, The North Quarter, Fettes Park 496 Ferry Road, Edinburgh, EH5 2DL. We will attempt to resolve your issue in a timeous, reasonable and amicable manner. However, if you are unsatisfied with our response, you can contact IPSO, which will investigate the matter. You can either telephone IPSO on 0300 123 2220 or email inquiries@ipso.co.uk. IPSO is an independent body which deals with complaints from the public about the editorial content of newspapers and magazines. We will abide by the decision of IPSO.